Your browser doesn't support javascript.
loading
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia.
Khalil, Alaeddin; Würthwein, Gudrun; Golitsch, Jana; Hempel, Georg; Fobker, Manfred; Gerss, Joachim; Möricke, Anja; Zimmermann, Martin; Smisek, Petr; Zucchetti, Massimo; Nath, Christa; Attarbaschi, Andishe; Von Stackelberg, Arend; Gökbuget, Nicola; Rizzari, Carmelo; Conter, Valentino; Schrappe, Martin; Boos, Joachim; Lanvers-Kaminsky, Claudia.
Afiliação
  • Khalil A; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster.
  • Würthwein G; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster.
  • Golitsch J; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster.
  • Hempel G; Department of Pharmaceutical and Medical Chemistry, Clinical Pharmacy, University of Muenster.
  • Fobker M; Center of Laboratory Medicine, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149 Muenster.
  • Gerss J; Institute of Biostatistics and Clinical Research, University of Muenster.
  • Möricke A; Department of Pediatrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel.
  • Zimmermann M; Department of Pediatric Hematology and Oncology, Medical School Hannover.
  • Smisek P; Department of Pediatric Hematology and Oncology, University Hospital Motol, Praha, Czech Republic.
  • Zucchetti M; Laboratory of Cancer Pharmacology, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan.
  • Nath C; Departments of Biochemistry and Oncology, The Children's Hospital at Westmead, Sydney Pharmacy School, University of Sydney, Sydney.
  • Attarbaschi A; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna.
  • Von Stackelberg A; Departments of Pediatric Oncology/Hematology and of General Pediatrics, Charité - University Medicine Berlin, Berlin.
  • Gökbuget N; Department of Medicine, University Hospital, Frankfurt a.M.
  • Rizzari C; Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation, ASST-Monza, Monza.
  • Conter V; Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation, ASST-Monza, Monza.
  • Schrappe M; Department of Pediatrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel.
  • Boos J; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster.
  • Lanvers-Kaminsky C; Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster. lanvers@uni-muenster.de.
Haematologica ; 107(1): 49-57, 2022 01 01.
Article em En | MEDLINE | ID: mdl-33299233
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Adult / Child / Humans / Infant Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Adult / Child / Humans / Infant Idioma: En Ano de publicação: 2022 Tipo de documento: Article